Home » Authors » Anette Breindl

Articles by Anette Breindl

Studies Show Importance of Realistic Experimental Conditions

March 12, 2009

By Anette Breindl

With Advances In Genomics, Exosomes Broaden Horizons

March 10, 2009

By Anette Breindl

New Microbicide Shows Promise, Though Occult Infection Puzzling

March 5, 2009

By Anette Breindl

Two Studies Report Paradoxical Effects of Angiogenesis Inhibitors

March 4, 2009

By Anette Breindl

Combo of FDA-Approved Drugs Effective Against Normal, XDR TB

Feb. 27, 2009

By Anette Breindl

Normal Prion Protein is Found to Play Role in Alzheimer's Disease

Feb. 26, 2009

By Anette Breindl

New Antibodies Effective Against Seasonal, Pandemic Flu Strains

Feb. 24, 2009

By Anette Breindl

New Compound Effective mTOR Blocker; Mechanism Unexpected

Feb. 20, 2009

By Anette Breindl

Test may separate benign from aggressive prostate cancer

Feb. 19, 2009

By Anette Breindl

Targeting Osteoclast Precursor Could Alleviate Osteoporosis

Feb. 19, 2009

By Anette Breindl

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Viva in vivo! At EHA, in vivo CAR T data continues to impress
BioWorld
Treatment with first-generation CAR T cells regularly sent patients to the intensive care unit. Now, investigators are envisioning a future where CAR T treatment...